Nanorod-Based Detection Platforms

Uniform spherical gold nanoparticles applicable in immunodiagnostic assays and molecular detection. Enable colorimetric detection and signal amplification in diagnostic test platforms.

Optimized enzyme components for nucleic acid amplification and detection in molecular diagnostics. Provides consistent performance in various assay formulations and detection platforms.

Integrated microfluidic platforms for molecular-level disease detection and pathogen identification. Combines sample preparation, amplification, and detection in a single miniaturized device for clinical diagnostics.

A comprehensive diagnostic system combining Nanotrap technology with deep learning analysis for accurate disease detection and progression monitoring. The platform provides comprehensive diagnostic coverage from screening to advanced diagnosis.

Molecular diagnostics platform for nucleic acid detection and amplification-based testing. Enables identification of pathogens and genetic markers for infectious disease and other molecular-based diagnoses.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

Next-generation bioanalytical assay format based on encoded nanoreactors with magnetic and fluorescence properties. Enables rapid development and deployment of diagnostic tests for various analytes and clinical conditions.

Systems and reagents for nucleic acid detection and quantification in cell and gene therapy applications. Supports quality control and process monitoring in biopharmaceutical manufacturing.

Molecular analysis system for detection of nucleic acids and genetic material. Enables identification of pathogens, genetic mutations, and infectious agents at molecular level.

Complete diagnostic kit systems incorporating functionalized nanoparticles and reagents for clinical testing. Enable rapid immunoassay and molecular diagnostic procedures.

Magnetic Fluorescence Encoded Nanoreactor platform technology for developing diagnostic assays with minimal cross-interference. Enables rapid creation and deployment of multi-analyte diagnostic tests across various disease conditions and clinical applications.

A molecular diagnostic platform for nucleic acid detection and analysis in clinical laboratory settings. Provides results for infectious disease and genetic testing applications.